BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11420662)

  • 1. Regulation of p53 expression by the RAS-MAP kinase pathway.
    Agarwal ML; Ramana CV; Hamilton M; Taylor WR; DePrimo SE; Bean LJ; Agarwal A; Agarwal MK; Wolfman A; Stark GR
    Oncogene; 2001 May; 20(20):2527-36. PubMed ID: 11420662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways.
    Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD
    Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells.
    Anders M; Christian C; McMahon M; McCormick F; Korn WM
    Cancer Res; 2003 May; 63(9):2088-95. PubMed ID: 12727824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
    Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
    Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R; Tulasne D; Kherrouche Z; Plaza S; Leroy C; Reveneau S; Vandenbunder B; Fafeur V
    Oncogene; 2002 Apr; 21(15):2309-19. PubMed ID: 11948414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and role of MAP kinase-dependent pathways in retinal pigment epithelial cells: ERK and RPE cell proliferation.
    Hecquet C; Lefevre G; Valtink M; Engelmann K; Mascarelli F
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):3091-8. PubMed ID: 12202534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein.
    Giambartolomei S; Covone F; Levrero M; Balsano C
    Oncogene; 2001 May; 20(20):2606-10. PubMed ID: 11420671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
    Gulati AP; Yang YM; Harter D; Mukhopadhyay A; Aggarwal BB; Benzil DL; Whysner J; Albino AP; Murali R; Jhanwar-Uniyal M
    Mol Carcinog; 2006 Jan; 45(1):26-37. PubMed ID: 16267831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite long-term regulation of c-Myc and p27Kip1 through overactivation of Raf-1 and the MEK/ERK module in proliferating human choroidal melanoma cells.
    Lefevre G; Calipel A; Mouriaux F; Hecquet C; Malecaze F; Mascarelli F
    Oncogene; 2003 Dec; 22(55):8813-22. PubMed ID: 14654778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the MAP kinase pathways in induction of GADD45 following UV radiation.
    Tong T; Fan W; Zhao H; Jin S; Fan F; Blanck P; Alomo I; Rajasekaran B; Liu Y; Holbrook NJ; Zhan Q
    Exp Cell Res; 2001 Sep; 269(1):64-72. PubMed ID: 11525640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53.
    Lee SW; Fang L; Igarashi M; Ouchi T; Lu KP; Aaronson SA
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8302-5. PubMed ID: 10890907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M; Darley M; Primrose JN; Blaydes JP
    Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-dependent protein kinase inhibitor (OK-1035) suppresses p21 expression in HCT116 cells containing wild-type p53 induced by adriamycin.
    Take Y; Kumano M; Teraoka H; Nishimura S; Okuyama A
    Biochem Biophys Res Commun; 1996 Apr; 221(2):207-12. PubMed ID: 8619835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation.
    Seddighzadeh M; Zhou JN; Kronenwett U; Shoshan MC; Auer G; Sten-Linder M; Wiman B; Linder S
    Clin Exp Metastasis; 1999; 17(8):649-54. PubMed ID: 10919709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of Ras-dependent signaling pathways controlling aggressive tumor growth of human fibrosarcoma cells: evidence for a potential novel pathway.
    Gupta S; Plattner R; Der CJ; Stanbridge EJ
    Mol Cell Biol; 2000 Dec; 20(24):9294-306. PubMed ID: 11094080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant p53 is constitutively phosphorylated at Serine 15 in UV-induced mouse skin tumors: involvement of ERK1/2 MAP kinase.
    Melnikova VO; Santamaria AB; Bolshakov SV; Ananthaswamy HN
    Oncogene; 2003 Sep; 22(38):5958-66. PubMed ID: 12955074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
    Fukasawa K; Vande Woude GF
    Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Erk1/Erk2 and transiently increased p53 levels together may account for p21 expression associated with phorbol ester-induced transient growth inhibition in HepG2 cells.
    Sipeki S; Bander E; Ways DK; Faragó A
    Cell Signal; 2002 Feb; 14(2):115-21. PubMed ID: 11781135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.